Genolmmune Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
10
Genolmmune Therapeutics General Information
Description
Developer of an advanced biotechnology designed to serve in the treatment of tumor immune cells. The company uses advanced life digital technology to stimulate the vitality of the human immune system against tumors and develop new advanced prevention and treatment programs targeting tumor-specific antigens to benefit patients.
Contact Information
Website
www.genoimmune.comCorporate Office
- 5th Floor, Building 5, Biomedical Park
- No. 388, Gaoxin 2nd Road, New Technology Development Zone
- Wuhan, Hubei 430079
- China
Corporate Office
- 5th Floor, Building 5, Biomedical Park
- No. 388, Gaoxin 2nd Road, New Technology Development Zone
- Wuhan, Hubei 430079
- China
Genolmmune Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 28-Dec-2022 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 12-Aug-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | 08-Dec-2020 | $15.2M | $33.1M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 20-Mar-2019 | $17.9M | $17.9M | Completed | Generating Revenue |
Genolmmune Therapeutics Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BGI Co-Win | Corporate Venture Capital | Minority | ||
| Kunshan Industrial Technology Research Institute | Government | Minority | ||
| TFTR Investment | Corporate Venture Capital | Minority | ||
| Forebright Capital | PE/Buyout | Minority | ||
| GL Ventures | Venture Capital | Minority |
Genolmmune Therapeutics FAQs
-
When was Genolmmune Therapeutics founded?
Genolmmune Therapeutics was founded in 2017.
-
Where is Genolmmune Therapeutics headquartered?
Genolmmune Therapeutics is headquartered in Wuhan, China.
-
What industry is Genolmmune Therapeutics in?
Genolmmune Therapeutics’s primary industry is Drug Discovery.
-
Is Genolmmune Therapeutics a private or public company?
Genolmmune Therapeutics is a Private company.
-
What is Genolmmune Therapeutics’s current revenue?
The current revenue for Genolmmune Therapeutics is .
-
How much funding has Genolmmune Therapeutics raised over time?
Genolmmune Therapeutics has raised $41.9M.
-
Who are Genolmmune Therapeutics’s investors?
BGI Co-Win, Kunshan Industrial Technology Research Institute, TFTR Investment, Forebright Capital, and GL Ventures are 5 of 10 investors who have invested in Genolmmune Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process